Categories: News

VaxAtlas Launches COVID-19 Platform To Help Navigate Vaccination Process

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOSTON, Dec. 16, 2020 /PRNewswire/ — VaxAtlas Inc., the leader in vaccine management, today announced the launch of a digital platform to support the COVID-19 vaccination process, making it easy for anyone to schedule and manage their vaccinations. Through a comprehensive suite of on-demand tools, VaxAtlas manages the process of getting COVID vaccinations from beginning to end. The platform provides access to a national certified pharmacy network for local appointment scheduling, recall alerts, second dose reminders, as well as QR clearance passes for vaccine validation. VaxAtlas alleviates the complexity associated with vaccine logistics and helps to get people back to work and back to living their lives.

For over 15 years VaxAtlas has been on the forefront of vaccine management as the backend that supported the H1N1 pandemic as well as Medicare Part D transition. Building off past experience, the current platform features a wide range of tools including access to a network of over 60,000 trusted national pharmacy providers including community pharmacies in areas hardest hit by the pandemic. The app provides easy location based scheduling to locations offering the vaccine, alerts for updates on outbreaks and recalls and second dose scheduling reminders. The product is HIPAA compliant and leverages current payment and eligibility standards. In addition, receive credible vaccination validation with scannable QR codes.

“With no structured approach to reopening, the vaccine management process will be confusing and hard to navigate”, said Judi Korzec, CEO & founder, VaxAtlas. “We want to alleviate the chaos and confusion of waiting in lines, scheduling or being turned away because of supply issues while providing tools to make lives easier for families, employers, travelers and physicians”.

VaxAtlas provides consumers with a full range of vaccination options from infants to seniors, travel and seasonal. Through convenient app based scheduling anyone anywhere can find a trusted pharmacy, receive reminders, alerts and family vaccinations records compiled into one convenient place.  For employers, VaxAtlas provides portable vaccination options including employer visibility and dashboards into COVID hotspots and outbreaks, vaccination uptake and tools to help manage employee communication, all to ensure a safer workplace.

Be the first to know when the vaccination is available in your area by signing up for COVID-19 notifications, scheduling and updates at www.vaxatlas.com.

About VaxAtlas:

VaxAtlas Inc. provides employers and consumers a comprehensive and portable approach to vaccination and testing management. We work with employers, schools, entertainment venues, travel services and consumers to complete “the last mile” of the COVID-19 Vaccination. For more information visit www.vaxatlas.com

  • VaxVault: Lifetime, portable vaccination record for individuals and families
  • VaxPass: Vaccination validation with scannable QR or printable format

View original content:http://www.prnewswire.com/news-releases/vaxatlas-launches-covid-19-platform-to-help-navigate-vaccination-process-301193866.html

SOURCE VaxAtlas

Staff

Recent Posts

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Basal Cell Carcinoma…

14 minutes ago

Glow Lifetech Provides Commercial Update; Expands to 1000+ Stores in Ontario and Achieves #2 Oil Brand with MOD

Toronto, Ontario--(Newsfile Corp. - June 23, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

14 minutes ago

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

20 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

20 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

23 hours ago